ICS 2016 Scientific Podium Short Oral Session S4 - Male Lower Urinary Tract Symptoms

Male Lower Urinary Tract Symptoms - Should We Treat Only the Prostate?

Scientific Podium Short Oral Session S4

Speakers
	Wednesday 14th September 2016
	10:30 - 12:00
	Hall C Capacity: 1500
C Carlos Levi D'Ancona ICS Chair M Masayuki Takeda ICS Chair A Alex Tong-Long Lin ICS Chair

Session Schedule

10:30

#31 Computational fluid dynamics simulation of male voiding: a novel method using real-time magnetic resonance image
PRIZE AWARD: Best Video Abstract

Soh S¹, Iwahata T¹, Suzuki K¹, Shimomura Y¹, Kobayashi T¹, Sadaoka Y¹, Ashizawa Y¹, Shin T¹, Kobori Y¹, Yagi H¹, Arai G¹, Okada H¹
1. Dokkyo Medical University Koshigaya Hospital
Anatomy, Male, Imaging, Urodynamics Techniques, Pathophysiology

10:37

#32 Flow time and voiding time – definitions and use in identifying detrusor underactivity

Gammie A¹, Yoshida S², Steup A², Kaper M², Dorrepaal C², Kos T², Abrams P¹
1. Bristol Urological Institute, 2. Astellas Pharma Europe B.V.
Underactive Bladder, Urodynamics Equipment, Urodynamics Techniques

10:45

#33 Compensation mechanism in bladder outlet obstruction (BOO) – thinking outside the box

Alloussi S H¹, Schnabel S¹, Bleser T², Alsfasser A¹, Alloussi S¹
1. Diakonie Klinikum Neunkirchen, 2. Winterberg Klinikum Saarbrücken
Bladder Outlet Obstruction , Detrusor Hypocontractility, Detrusor Overactivity

10:52

#34 International Continence Society definition of detrusor underactivity; analysis of clinical parameters and comparison with contractility grading methods

ten Donkelaar C¹, Rosier P¹, de Kort L¹
1. University Medical Center Utrecht
Detrusor Hypocontractility, Male, Retrospective Study, Underactive Bladder, Voiding Dysfunction

11:00

#35 Are LUTS an independent indicator of cardiovascular disease (CVD) development? A cross-sectional and longitudinal analysis in middle-aged to elderly men

Martin S¹, Vincent A¹, Adams R¹, Taylor A¹, O'Louglin P², Wittert G¹
1. University of Adelaide, 2. SA Pathology
Male, Prospective Study, Voiding Dysfunction

11:07

#36 A combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Suzuki T¹, Otsuka A¹, Ozono S¹
1. Hamamatsu University School of Medicine
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Male

11:15

#37 What is the additional burden for patients with detrusor underactivity when they also have detrusor overactivity?

Abrams P¹, Gammie A¹, Yoshida S², Steup A², Kaper M³, Dorrepaal C³, Kos T²
1. Bristol Urological Institute, 2. Astellas Pharma Europe B.V., 3. Astellas Pharma Europe B.V
Underactive Bladder, Detrusor Overactivity, Detrusor Hypocontractility, Overactive Bladder

11:22

#38 Discontinuation of alpha-blocker therapy in male lower urinary tract symptoms: a systematic review

Hordijk I¹, Korteschiel L², Steffens M², Lisman-van Leeuwen Y¹, Blanker M¹
1. University Medical Center Groningen, department of General Practice, 2. Isala Clinics, department of urology
Male, Benign Prostatic Hyperplasia (BPH), Clinical Trial, Voiding Dysfunction

11:30

#39 Prescription patterns of alpha-blockers for male Lower Urinary Tract Symptoms in Dutch men.

Hordijk I¹, Blanker M¹, Hak E²
1. University Medical Center Groningen, department of General Practice, 2. University of Groningen, Groningen Research Institute of Pharmacy
Benign Prostatic Hyperplasia (BPH), Conservative Treatment, Male

11:37

#40 Combination of solifenacin with tamsulosin but not tamsulosin affects morphometric and functional parameters of the prostate in patients with benign prostate enlargement (BPE) and overactive bladder (OAB). Results from a randomized pilot study.

Sakalis V¹, Sfiggas V¹, Vouros I¹, Salpiggidis G¹, Papathanasiou A¹, Apostolidis A²
1. Department of Urology, Ippokration Hospital, Thessaloniki, Greece, 2. 2nd Department of Urology, Aristotle University of Thessaloniki, Greece
Benign Prostatic Hyperplasia (BPH), Detrusor Overactivity, Overactive Bladder, Pharmacology, Pathophysiology

11:45

#41 Therapeutic efficacy and safety of mirabegron monotherapy in male overactive bladder patients with and without bladder outlet obstruction

Liao C¹, Lee C², Lee Y², Kuo H²
1. Department of Urology, Cardinal Tien Hospital and School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Bladder Outlet Obstruction , Pharmacology, Clinical Trial

11:52

#42 Men undergoing transurethral prostate surgery (TURP) for acute urinary retention (AUR) tied to earlier death.

Chan C¹, Ng C¹, Chan S¹, Chiu P K F², Yee S C H¹, Wong J H M¹, Teoh J Y C³, Yuen S K K⁴, Hou S M⁴
1. SH Ho Urology Centre, Division of Urology, Dept. of Surgery, The Chinese University of Hong Kong, 2. SH Ho Urology Centre, Division of Urology, Dept. of Surgery, The Chinese Univerisity of Hong Kong, 3. SH Ho Urology Centre, Division of Urology, Dept of Surgery, The Chinese University of Hong Kong, 4. SH Ho Urology Centre, Division of Urology, Department of Surgery, The Chinese University of Hong Kong
Surgery, Benign Prostatic Hyperplasia (BPH), Gerontology, Male, Retrospective Study